These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2191420

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Statins and stroke prevention: focus on women.
    Bushnell CD.
    Ital Heart J; 2004 Aug; 5(8):569-71. PubMed ID: 15554026
    [No Abstract] [Full Text] [Related]

  • 24. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
    Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A.
    CMAJ; 2005 Apr 12; 172(8):1027-31. PubMed ID: 15824409
    [No Abstract] [Full Text] [Related]

  • 25. Management of dyslipidemia in patients with complicated metabolic syndrome.
    Davidson MH.
    Am J Cardiol; 2005 Aug 22; 96(4A):22E-25E. PubMed ID: 16098839
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK.
    Am J Manag Care; 2002 Sep 22; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Drug therapy of severe hypercholesterolemia.
    Weizel A, Richter WO.
    Eur J Med Res; 1997 Jun 16; 2(6):265-9. PubMed ID: 9182654
    [Abstract] [Full Text] [Related]

  • 30. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A.
    Med Clin (Barc); 1995 Nov 25; 105(18):719. PubMed ID: 8538262
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D.
    Nurse Pract; 1997 Nov 25; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Summary of the role of statins in the treatment of dyslipidemia.
    Carr LL.
    J Am Osteopath Assoc; 2003 Jul 25; 103(7 Suppl 3):S1-3. PubMed ID: 12884937
    [No Abstract] [Full Text] [Related]

  • 36. Dyslipidemia and coronary artery disease.
    Kuo PT.
    Clin Cardiol; 1994 Oct 25; 17(10):519-27. PubMed ID: 8001298
    [Abstract] [Full Text] [Related]

  • 37. [Treatment of hypercholesterolemia with enzyme inhibitors].
    Valdés EF.
    Medicina (B Aires); 1988 Oct 25; 48(4):425-8. PubMed ID: 3076202
    [No Abstract] [Full Text] [Related]

  • 38. Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease.
    Ferdinand KC.
    Curr Med Res Opin; 2005 Jul 25; 21(7):1091-7. PubMed ID: 16004678
    [Abstract] [Full Text] [Related]

  • 39. [Probucol].
    Ayaori M, Ogura M, Kusuhara M.
    Nihon Rinsho; 2007 Jul 28; 65 Suppl 7():470-5. PubMed ID: 17824073
    [No Abstract] [Full Text] [Related]

  • 40. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W.
    MMW Fortschr Med; 2003 Oct 09; 145(41):48. PubMed ID: 14655487
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.